Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie

TheMotleyFool

0 0

Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie: https://g.foolcdn.com/editorial/images/726179/gettyimages-researcher-works-in-lab_computer.jpg

Vertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market. In fact, in 2022 these dynamic biotech stocks climbed by percentages in the double digits, and for good reason. People need medicines no matter what the market is doing -- and this helps healthcare companies maintain earnings during good times and bad, making them solid investments in tough economies.

Vertex and AbbVie also happen to offer a lot of growth potential. Vertex has a new potential blockbuster drug on the horizon. And AbbVie may become the leader in prescription-drug market share within the next few years.

Which of these superstar stocks is the better growth pick right now? Let's find out.

Source Fool.com

Like: 0

VRTX

Share